Choosing the right delivery system for glutathione is not a one-size-fits-all decision. The raw material’s behavior — how stable it remains, how effectively it’s absorbed, how it handles manufacturing processes — changes depending on the form you’re putting it into. Understanding these differences before you finalize a formulation saves significant rework time and protects the integrity of the ingredient through to the finished product.
Standard Capsules: The Baseline Case
The most common format for glutathione supplementation is a straightforward hard capsule — typically HPMC or gelatin — filled with reduced glutathione powder and whatever excipients are needed for flow and fill weight consistency.
This format works reliably at doses from 250mg to 500mg per capsule. The main stability concern is moisture: reduced glutathione oxidizes over time, and if the capsule shell or fill allows moisture ingress, the active compound converts to the oxidized form and loses biological activity. Desiccant in the bottle, foil laminate packaging, and low-moisture excipients are standard risk controls. The powder should come in at ≤2% moisture content, and the finished capsule should be packaged to maintain that.
Particle size matters more in capsule filling than buyers sometimes expect. A very fine powder (D50 below 50 microns) tends to have poor flow properties and causes bridging in capsule filling machines, increasing fill weight variation. A slightly coarser powder, or one that has been granulated, flows more predictably. When spec’ing the raw material for a capsule format, ask the supplier for their typical particle size distribution and match it to your equipment.
Liposomal Formulations: Higher Bioavailability, Higher Complexity
Liposomal glutathione encapsulates the molecule in phospholipid vesicles that can merge with cell membranes and deliver the active ingredient intracellularly without requiring intact absorption through standard intestinal pathways. Multiple clinical studies have shown higher blood glutathione elevations from liposomal formats compared to equivalent doses of standard capsules.
The raw material requirements for liposomal production differ from capsule requirements. The glutathione powder needs to dissolve completely in the aqueous phase used during the liposome preparation process — this means very high purity (≥99% is typical for liposomal grade) and fine particle size to ensure full dissolution before encapsulation. Any undissolved particles can disrupt the homogeneity of the liposome emulsion and reduce encapsulation efficiency.
Oxidative stability during the manufacturing process is also a concern. Liposome preparation involves aqueous mixing under heat, which can accelerate oxidation of the thiol group that makes reduced glutathione biologically active. Working under inert gas (nitrogen or argon) during mixing and encapsulation steps reduces this risk. The supplier’s material should have a thiol content assay showing that the reduced form is intact; a high overall purity with a low thiol content suggests partial oxidation before or during processing.
Effervescent Tablets: Stability Challenges at Every Step
Effervescent formats — tablets or sachets that dissolve in water before ingestion — are popular for premium positioning and consumer experience. Glutathione in an effervescent format presents particular stability challenges because the manufacturing and storage conditions are especially demanding.
Effervescent tablet production involves mixing the active with citric acid and sodium bicarbonate, the components that create the dissolution reaction. Both are hygroscopic — they attract moisture from the air — and even small amounts of moisture in the blend can trigger premature reaction and degrade the tablet’s structural integrity. This means the entire production process, from blending through compression and packaging, has to be conducted in low-humidity environments, typically below 25% relative humidity.
Reduced glutathione’s thiol chemistry makes it reactive with some common excipients under certain conditions. Compatibility testing against the full excipient list is essential before committing to production scale. Antioxidant co-formulants — vitamin C in particular — can help protect the glutathione from oxidation in the dissolved state, but they also add formulation complexity and may affect taste and pH.
Powder Blends and Stick Packs: The Convenience Format
Glutathione in a powder blend or stick pack format is straightforward from a manufacturing standpoint compared to liposomal or effervescent production, but requires attention to the same core issues: moisture, particle compatibility, and oxidative stability.
The main practical difference in powder blend applications is that the glutathione powder is often mixed with other active ingredients, each with their own particle size distribution and density. Blending disparate particle sizes and densities creates segregation risk — the components separate during handling, transport, and dispensing, leading to dose inconsistency. A formulation intended for stick packs where the consumer pours the packet directly into water is particularly sensitive to this, because a non-homogeneous blend delivers inconsistent doses across units.
Requesting that your supplier provide a particle size distribution report, not just a median D50, allows you to assess compatibility with the other ingredients in your blend before committing to production.
